Historical record - last NADAC effective date: 9/18/2024
Product Information
ZEGERID 40 MG CAPSULE is a brand product labeled by Santarus Inc., priced at $105.8645 per EA under NDC 68012010430. Its NADAC has been published 170 times since Nov 19, 2014.
FDA first approved this application on Feb 27, 2006.
The High Outlier badge above means this manufacturer's average price in the omeprazole and sodium bicarbonate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40; 1100 mg/1; mg/1
Manufacturer
Santarus Inc.NDC
68012010430
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
New Drug (NDA)
FDA Application
NDA021849FDA Approved
2/27/2006
On Market Since
2/27/2006
Pharmacological Classes
Price Statistics
The NADAC for ZEGERID 40 MG CAPSULE has been published 170 times since Nov 19, 2014, and over the history we have for it it has risen 754.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $105.8645 per EA |
|---|---|
| All-time high | $106.0718 (May 15, 2024) |
| All-time low | $12.0951 (Jun 17, 2015) |
| Median price | $95.7072 |
| Average price | $79.2103 |
| Largest weekly change | +500.0% (Sep 16, 2015) |
| Weeks tracked | 170 |
| Tracking since | Nov 19, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+10.6%
5Y
+10.6%
All
+754.4%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole and sodium bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Santarus Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omeprazole and sodium bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZEGERID 40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZEGERID 40 MG CAPSULE, manufactured by Santarus Inc., is $105.8645 per EA (NDC 68012010430), effective Sep 10, 2025.
How has the price of ZEGERID 40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZEGERID 40 MG CAPSULE has risen 754.4%. It has been tracked across 170 weekly CMS publications since Nov 19, 2014.
What are the highest and lowest recorded NADAC prices for ZEGERID 40 MG CAPSULE?
Since Nov 19, 2014, the NADAC for ZEGERID 40 MG CAPSULE has ranged from a low of $12.0951 (Jun 17, 2015) to a high of $106.0718 (May 15, 2024), with a median of $95.7072 per EA.
Are there cheaper alternatives to ZEGERID 40 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ZEGERID 40 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ZEGERID 40 MG CAPSULE?
ZEGERID 40 MG CAPSULE (NDC 68012010430) is labeled by Santarus Inc., and CMS classifies it as a brand product.